News
This Simple Dietary Switch Could Be a Game-Changer for Women With Diabetes, Endocrinologists Say first appeared on Parade on ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...
7d
Clinical Trials Arena on MSNVertex presents data from Phase I/II stage of trial for type 1 diabetesThe safety profile of the therapy was found to be favourable, without any serious adverse events linked to the treatment.
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
3d
HealthDay on MSNADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 DiabetesOnce-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results